Prelude Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $259K | Buy |
|
|||||
|
2025
Q1 | $226K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $612K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $497K | Buy |
|
|||||
|
2023
Q1 | $403K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $723K | Buy |
|
|||||
|
2021
Q3 | $497K | Sell |
|
|||||
|
2021
Q2 | $1.11M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $549K | Buy |
|
|||||
|
2020
Q3 | $492K | Sell |
|
|||||
|
2020
Q2 | $791K | Buy |
|
|||||
|
2020
Q1 | $67K | Sell |
|
|||||
|
2019
Q4 | $889K | Buy |
|
|||||
|
2019
Q3 | $13K | Sell |
|
|||||
|
2019
Q2 | $649K | Buy |
|
|||||
|
2019
Q1 | $218K | Sell |
|
|||||
|
2018
Q4 | $647K | Sell |
|
|||||
|
2018
Q3 | $873K | Buy |
|
|||||
|
2018
Q2 | $631K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $723K | Buy |
|
|||||
|
2017
Q2 | $306K | Buy |
|
|||||
|
2017
Q1 | $197K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $523K | Sell |
|
|||||
|
2015
Q3 | $680K | Sell |
|
|||||
|
2015
Q2 | $852K | Sell |
|
|||||
|
2015
Q1 | $782K | Buy |
|
|||||
|
2014
Q4 | $316K | Sell |
|
|||||
|
2014
Q3 | $376K | Buy |
|
|||||
|
2014
Q2 | $229K | Sell |
|
|||||
|
2014
Q1 | $562K | Sell |
|
|||||
|
2013
Q4 | $609K | Hold |
|
|||||
|
2013
Q3 | $692K | Sell |
|
|||||
|
2013
Q2 | $1.17M | Buy |
|